川宁生物
(301301)
| 流通市值：74.34亿 | | | 总市值：268.82亿 |
| 流通股本：6.16亿 | | | 总股本：22.27亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 624,172,142.98 | 929,120,304.76 | 889,716,110.6 | 760,935,778.29 |
| 应收票据及应收账款 | 1,030,260,734.68 | 937,986,647.37 | 821,449,661.85 | 748,089,910.65 |
| 应收账款 | 1,030,260,734.68 | 937,986,647.37 | 821,449,661.85 | 748,089,910.65 |
| 应收款项融资 | 1,152,885,354.44 | 1,128,288,662.72 | 1,113,523,155.86 | 655,395,375.17 |
| 预付款项 | 331,334,519.69 | 104,602,965.65 | 131,042,579.66 | 44,902,321.12 |
| 其他应收款合计 | 1,381,331.85 | 1,400,724.65 | 1,385,208.45 | 631,286.77 |
| 存货 | 896,831,183.83 | 920,617,663.5 | 1,360,665,716.81 | 1,676,440,163.24 |
| 其他流动资产 | 50,599,588.17 | 58,140,014.37 | 50,982,297.35 | 70,040,398.7 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 4,088,077,855.64 | 4,080,156,983.02 | 4,368,764,730.58 | 3,956,435,233.94 |
| 非流动资产: | | | | |
| 长期股权投资 | 16,218,376.88 | 16,478,172.07 | 6,744,841.04 | 6,783,731.63 |
| 其他权益工具投资 | 25,000,000 | 25,000,000 | 25,000,000 | 0 |
| 固定资产 | 5,404,315,012.36 | 4,921,711,890.19 | 5,032,532,885.97 | 5,141,044,277.8 |
| 在建工程 | 190,320,715.8 | 753,825,004.26 | 649,459,968.56 | 537,801,355.84 |
| 使用权资产 | 507,499,991.03 | 502,289,845.48 | 190,067,692.53 | 191,521,286.55 |
| 无形资产 | 241,004,092.28 | 245,479,966.67 | 251,446,836.21 | 257,986,250.78 |
| 商誉 | 1,365,974 | 1,365,974 | 1,365,974 | 1,365,974 |
| 长期待摊费用 | 1,756,506.01 | 1,976,069.26 | 2,195,632.51 | 2,415,195.76 |
| 递延所得税资产 | 28,264,505.59 | 27,047,851.7 | 21,295,922.21 | 21,653,051.13 |
| 其他非流动资产 | 47,553,464.34 | 23,833,323.93 | 24,994,141.34 | 21,642,770.12 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 6,463,298,638.29 | 6,519,008,097.56 | 6,205,103,894.37 | 6,182,213,893.61 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 10,551,376,493.93 | 10,599,165,080.58 | 10,573,868,624.95 | 10,138,649,127.55 |
| 流动负债: | | | | |
| 短期借款 | 320,177,944.45 | 750,598,611.13 | 850,750,138.88 | 850,681,944.46 |
| 交易性金融负债 | - | 256,100 | 551,433.21 | 31,500 |
| 应付票据及应付账款 | 688,996,579.63 | 783,994,852.23 | 985,255,137.89 | 1,010,423,025.64 |
| 其中：应付票据 | - | 0 | 293,463,600 | 293,463,600 |
| 应付账款 | 688,996,579.63 | 783,994,852.23 | 691,791,537.89 | 716,959,425.64 |
| 合同负债 | 77,647,641.86 | 18,416,264.19 | 55,362,293.43 | 28,943,773.5 |
| 应付职工薪酬 | 26,688,998 | 26,291,277.33 | 24,833,281.64 | 29,935,476.28 |
| 应交税费 | 117,137,198.79 | 118,062,164.72 | 139,802,356.25 | 38,434,657.99 |
| 其他应付款合计 | 61,922,381.68 | 56,784,192.9 | 33,619,278.99 | 31,664,426.45 |
| 其中:应付利息 | - | - | 0 | - |
| 应付股利 | - | - | 0 | - |
| 一年内到期的非流动负债 | 699,539,727.29 | 365,957,064.5 | 382,989,826.61 | 542,162,597.27 |
| 其他流动负债 | 4,884,025.96 | 1,901,286.74 | 7,022,477.58 | 3,439,916.35 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 1,996,994,497.66 | 2,122,261,813.74 | 2,480,186,224.48 | 2,535,717,317.94 |
| 非流动负债: | | | | |
| 长期借款 | 392,999,999.99 | 650,000,000 | 482,999,999.99 | 357,333,333 |
| 租赁负债 | 473,060,592.3 | 458,290,832.62 | 193,701,456.69 | 188,119,270.4 |
| 预计负债 | 5,468,562.24 | 3,215,649.69 | 1,411,101.49 | 77,901.36 |
| 递延收益 | 93,499,201.38 | 94,562,306.19 | 82,335,411 | 83,738,515.81 |
| 递延所得税负债 | 142,431.49 | 94,557.36 | 20,702.58 | 307,275.99 |
| 其他非流动负债 | - | - | - | 0 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 965,170,787.4 | 1,206,163,345.86 | 760,468,671.75 | 629,576,296.56 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 2,962,165,285.06 | 3,328,425,159.6 | 3,240,654,896.23 | 3,165,293,614.5 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 2,227,160,000 | 2,227,160,000 | 2,222,800,000 | 2,222,800,000 |
| 资本公积 | 3,281,363,755.02 | 3,278,452,922.5 | 3,258,858,725.33 | 3,251,626,621.58 |
| 减:库存股 | - | - | 0 | - |
| 其他综合收益 | - | - | 0 | - |
| 专项储备 | - | - | 0 | - |
| 盈余公积 | 172,321,265.49 | 172,321,265.49 | 172,321,265.49 | 172,321,265.49 |
| 一般风险准备 | - | - | 0 | 0 |
| 未分配利润 | 1,889,524,921.26 | 1,579,910,487.94 | 1,666,350,780.61 | 1,313,735,906.19 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 7,570,369,941.77 | 7,257,844,675.93 | 7,320,330,771.43 | 6,960,483,793.26 |
| 少数股东权益 | 18,841,267.1 | 12,895,245.05 | 12,882,957.29 | 12,871,719.79 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 7,589,211,208.87 | 7,270,739,920.98 | 7,333,213,728.72 | 6,973,355,513.05 |
| 负债和股东权益合计 | 10,551,376,493.93 | 10,599,165,080.58 | 10,573,868,624.95 | 10,138,649,127.55 |
| 公告日期 | 2024-10-22 | 2024-08-27 | 2024-04-22 | 2024-04-22 |
| 审计意见(境内) | | | | 标准无保留意见 |